Apigenin inhibits growth and induces apoptosis in human cholangiocarcinoma cells. Subhasitanont P, Chokchaichamnankit D, Chiablaem K, Keeratichamroen S, Ngiwsara L, Paricharttanakul NM, Lirdprapamongkol K, Weeraphan C, Svasti J, Srisomsap C*. Oncol Lett 2017;14(4):4361-71.

01 Oct 2017
0
0

Apigenin inhibits growth and induces apoptosis in human cholangiocarcinoma cells.

Subhasitanont P, Chokchaichamnankit D, Chiablaem K, Keeratichamroen S, Ngiwsara L, Paricharttanakul NM, Lirdprapamongkol K, Weeraphan C, Svasti J, Srisomsap C*.

Oncol Lett 2017;14(4):4361-71.

Tags

Share this

Related Posts

Lertsuwan, K., Nammultriputtar, K., Nanthawuttiphan, S., Phoaubon, S., Lertsuwan, J., Thongbunchoo, J., . . . Charoenphandhu, N. (2018). Ferrous and ferric differentially deteriorate proliferation and differentiation of osteoblast-like UMR-106 cells. Biometals, 31(5), 873-889. doi:10.1007/s10534-018-0130-6
16 Jul 2018
0

Lertsuwan, K., Nammultriputtar, K., Nanthawuttiphan, S., Phoaubon, S., Lertsuwan, J., Thongbunchoo, J., . . . Charoenphandhu, N. (2018). Ferrous and ferric differentially deteriorate proliferation and differentiation of osteoblast-like UMR-106 cells. Biometals, 31(5), 873-889. doi:10.1007/s10534-018-0130-6

Lertsuwan, K., Nammultriputtar, K., Nanthawuttiphan, S., Phoaubon, S., Lertsuwan, J., Thongbunchoo, J., . . . Charoenphandhu, N. (2018). Ferrous and ferric differentially deteriorate proliferation and differentiation of osteoblast-like UMR-106 cells. Biometals, 31(5), 873-889. doi:10.1007/s10534-018-0130-6
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More